Wuppertal, Germany

Frank-Gerhard Böss

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank-Gerhard Böss. Retrieved from https://idiyas.com/inventor/frank-gerhard-bandoumlss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank-Gerhard Böss: Innovator in Medicinal Chemistry

Introduction

Frank-Gerhard Böss is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on substituted imidazotriazinones. His research focuses on enhancing cognitive functions such as perception, concentration, learning, and memory.

Latest Patents

Frank-Gerhard Böss holds a patent for "Substituted imidazotriazinones." This invention relates to new substituted imidazotriazinones, processes for their preparation, and their application in the production of medicaments aimed at improving cognitive abilities.

Career Highlights

Böss is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to explore and develop innovative solutions in the realm of medicinal chemistry.

Collaborations

Throughout his career, Frank-Gerhard Böss has collaborated with esteemed colleagues, including Ulrich Niewöhner and Dagmar Schauss. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Frank-Gerhard Böss exemplifies the spirit of innovation in medicinal chemistry, with his work paving the way for new treatments that enhance cognitive functions. His contributions are invaluable to the ongoing development of effective medicaments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…